Brokers usually take bids until: Zerodha 4:45 PM, Groww 4:50 PM, Angel One and Upstox 5:00 PM (HNI 4:00 PM). Check the exact time with your broker or bank.
Total Issue Size
Fresh Issue + Offer For Sale
Fresh Issue (FI)
Proceeds go to the company
Offer For Sale (OFS)
Proceeds go to the existing investors
Repayment or prepayment of outstanding borrowings
Prepayment and repayment of full or partial debt facilities availed by the company and its operating subsidiaries to reduce interest burden.
General corporate purposes
Funding general corporate requirements, strategic initiatives, operational expenses, and corporate administrative needs.
No documents added yet.
(₹ in Crore)
Tap a bar to highlight a metric across periods and show its values.
Krishna Institute of Medical Sciences Limited (KIMS) is one of the largest corporate healthcare chains in Andhra Pradesh and Telangana, providing comprehensive, multi-specialty integrated healthcare services. Founded by Dr. Bhaskara Rao Bollineni, the hospital group offers multi-disciplinary care across tertiary and quaternary specialties including cardiology, oncology, neurosciences, orthopedics, gastroenterology, and organ transplantation. The institution commenced operations with its flagship facility in Secunderabad and expanded its healthcare footprint across Tier 2 and Tier 3 cities in South India. As of March 2021, KIMS operated 9 multi-specialty hospitals with an aggregate bed capacity of over 3,000 beds, including more than 2,500 operational beds. The facilities are equipped with modern diagnostic equipment, intensive care units, and specialized operating theaters. KIMS follows an affordable healthcare model aimed at providing high-quality medical treatment to patients across diverse economic backgrounds. Its clinical teams comprise experienced doctors, surgeons, and healthcare professionals who deliver patient-centric care. The organization focuses on disciplined capital allocation, operational efficiency, and clinical excellence to drive sustainable growth in the healthcare sector.
Krishna Institute of Medical Sciences Limited allocated 1,15,84,060 equity shares to 43 anchor investors at the upper price band of Rs 825 per share, raising Rs 955.68 crore ahead of its public issue opening. Key anchor participants included Nomura, Fidelity, Eastspring Investments, HDFC Life, ICICI Prudential, and SBI Mutual Fund.
Source: RHP • Analysis provided for informational purposes
Last Updated: 28 July 2026, 4:10 AM
Leading Regional Healthcare Network
Establishes a strong market position as one of the largest healthcare providers in Andhra Pradesh and Telangana with extensive brand recognition.
Integrated Multi-Specialty Clinical Excellence
Delivers comprehensive tertiary and quaternary care across complex medical disciplines through experienced clinical personnel.
Disciplined Capital Allocation and Financial Discipline
Demonstrates efficient bed capacity expansion, strong return metrics, and consistent revenue growth supported by disciplined financial management.
Geographic Concentration Risk
A significant portion of revenues is generated from hospital facilities located primarily in Andhra Pradesh and Telangana.
Regulatory Oversight and Healthcare Compliance
Operations are subject to stringent health safety guidelines, medical licensing standards, and government price controls on certain medical devices and procedures.
Dependence on Key Medical Professionals
Failure to attract and retain highly qualified doctors, surgeons, and nursing staff could impact service quality and clinical reputation.
Krishna Institute of Medical Sciences Limited
MUFG Intime India Private Limited
No financial information whatsoever published anywhere, within this website, should be considered as an advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on information published on this website. The information on this website is based on information available as on date coupled with market perceptions.
You agree with the terms and conditions to use this website.
Grey-market disclaimer. GMP shown here is grey-market news only. We do not trade or deal in the grey market or subject-to rates, nor do we recommend trading in the grey market.
Not investment advice. IPO Nex is an information tool, not investment advice. We do not recommend buying or selling any securities. Always do your own research before applying to any IPO.
IPO Nex does not guarantee any listing gain or return. IPO investments are subject to market risks.
All times are IST.
© 2026 IPO Nex by Niota. All rights reserved.